Mario Gabelli Comments on Thoratec Corp

Guru stock highlight

Author's Avatar
Oct 19, 2015

Thoratec Corp. (THOR, Financial)(2.1%) (THOR – $63.26 – NASDAQ), headquartered in Pleasanton, California, designs, manufactures and sells products to treat the full range of clinical needs for patients suffering from advanced heart failure. On July 22, 2015, St. Jude Medical announced that it would acquire the company for $63.50 cash per share in a merger worth $3.4 billion. Following regulatory and shareholder approvals, the transaction is expected to close in the fourth quarter of 2015.

From Mario Gabelli (Trades, Portfolio)'s third quarter 2015 ABC Fund commentary.